BioCentury
ARTICLE | Top Story

Genzyme eclipses Street EPS

March 8, 2001 8:00 AM UTC

GENZ reported fourth quarter and full year EPS of $0.60 and $2.27, respectively, beating by $0.03 and $0.04 the consensus estimates. Net income for the year came in at $208.8 million, a 23 percent inc...